Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Strides, TLC collaborate to launch black fungus drug in India
The CDSCO has approved TLC's new drug application (NDA) of Amphotericin B Liposome for Injection 50 mg in India for immediate…
Significant adverse effect unlikely with doses of different COVID-19 vaccines, but further scrutiny…
It, however, clarified that both doses administered to an individual should be of the same vaccine as per the existing protocol
QAI launches accreditation program for Biobanks in India
Accreditation would facilitate cooperation, fosters exchange, and assists in the harmonisation of practices among biobanks,…
Bharat Biotech and Gujarat Covid Vaccine Consortium sign MoU for drug substance of COVAXIN
If everything goes as per the schedule, the drug substance would be available from August 2021
BDR Pharma launches generic Rucaparib to treat advanced ovarian and prostate cancers
Rucaparib is launched under the brand name BDPARIB in two strengths of 200 mg and 300 mg
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound
Lupin’s MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor…
Zydus seeks DCGI nod for clinical trials of monoclonal antibodies cocktail to treat COVID-19…
ZRC-3308 is a cocktail of two monoclonal antibodies targeting two unique epitopes on the spike protein of SARS-CoV-2
Tessol launches cold solutions for vaccine delivery
The startup has attained success in other industries where maintaining a cold chain during logistics is critical
Industry 4.0 technologies critical for India’s pharma supply chains to combat COVID-19
At an online forum, Rockwell Automations’ business leaders deliberated on how Industry 4.0 technologies enabled pharmaceuticals…
India might get Moderna’s single-dose COVID-19 vaccine next year; Pfizer offers five crore…
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited…